Last Price
0.077
Today's Change
-0.009 (10.46%)
Day's Change
0.077 - 0.085
Trading Volume
156,026
Market Cap
28 Million
Shares Outstanding
365 Million
Avg Volume
293,399
Avg Price (50 Days)
0.10
Avg Price (200 Days)
0.11
PE Ratio
-2.57
EPS
-0.03
Earnings Announcement
02-Sep-2025
Previous Close
0.09
Open
0.09
Day's Range
0.077 - 0.085
Year Range
0.077 - 0.185
Trading Volume
156,026
1 Day Change
-10.47%
5 Day Change
-10.47%
1 Month Change
-26.67%
3 Month Change
-17.20%
6 Month Change
-35.83%
Ytd Change
-20.62%
1 Year Change
-16.30%
3 Year Change
-26.67%
5 Year Change
-69.20%
10 Year Change
-69.20%
Max Change
-69.20%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.